Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Mach7 Technologies ( (AU:M7T) ) is now available.
Mach7 Technologies announced that their CEO and Managing Director, Teri Thomas, will present at the Bell Potter Healthcare Conference. This presentation is expected to reinforce Mach7’s position in the healthcare technology sector by showcasing their innovative imaging solutions, potentially impacting their market presence and stakeholder engagement.
The most recent analyst rating on (AU:M7T) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies is a leading provider of medical imaging software, offering advanced data management and diagnostic viewing solutions to healthcare organizations globally. Their Mach7 Enterprise Imaging Solution (EIS) includes a Vendor Neutral Archive (VNA), the eUnity Enterprise Diagnostic Viewer, and diagnostic workflow applications, designed for flexibility and scalability to support a wide range of healthcare networks.
YTD Price Performance: -21.25%
Average Trading Volume: 232,649
Technical Sentiment Signal: Sell
Current Market Cap: A$74.01M
Learn more about M7T stock on TipRanks’ Stock Analysis page.